Immediate Impact
18 standout
Citing Papers
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
2025 Standout
Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines
2025 Standout
Works of Agathe Ceppe being referenced
Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis
2023
A four week trial of hypertonic saline in children with mild cystic fibrosis lung disease: Effect on mucociliary clearance and clinical outcomes
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Agathe Ceppe | 318 | 18 | 37 | 68 | 65 | 35 | 514 | |
| Jacques A. Pralong | 257 | 11 | 38 | 14 | 43 | 26 | 649 | |
| Gerald Ullrich | 414 | 116 | 4 | 37 | 24 | 32 | 602 | |
| Gail Stewart | 96 | 6 | 4 | 36 | 47 | 31 | 619 | |
| Michael McDermott | 114 | 6 | 9 | 19 | 35 | 34 | 531 | |
| Dara Brodsky | 162 | 11 | 57 | 42 | 29 | 647 | ||
| Oisin O’Connell | 301 | 11 | 11 | 117 | 75 | 24 | 479 | |
| Hamed Habib | 123 | 21 | 4 | 27 | 25 | 30 | 542 | |
| Sally Wilson | 72 | 3 | 10 | 137 | 63 | 36 | 549 | |
| Lars Bruun Larsen | 109 | 15 | 11 | 27 | 59 | 44 | 572 | |
| Takashi Motegi | 388 | 12 | 3 | 108 | 162 | 45 | 637 |
All Works
Login with ORCID to disown or claim papers
Loading papers...